投稿信息
投稿信息
投稿命中率
審稿費用
暫無數(shù)據(jù)
版面費用
暫無數(shù)據(jù)
中國人發(fā)表比例
2023年中國人文章占該期刊總數(shù)量18.46% (2022年為3.64%)
自引率
3.9 %
年文章數(shù)
439
作者需知
暫無數(shù)據(jù)
NCBI查詢
偏重的研究方向
暫無數(shù)據(jù)
期刊簡介
稿件收錄要求
稿件收錄要求
Published by Adis International Limited (now part of Wolters Kluwer Health).
ISSN: 1173-8804.
BioDrugs keeps you up to date with the latest developments in the clinical application of biotechnology for the treatment of human disease.BioDrugs publishes high quality, peer-reviewed research and up- to-date, critical reviews on the clinical development and therapeutic application of biotechnology-based pharmaceuticals, diagnostic products, and innovative technologies. The journal is an essential resource for R & D professionals in the biomedical science industries and academia, and clinicians with an interest in the leading edge technology in this exciting area.
BioDrugs keeps you up to date with the latest developments in the clinical application of biotechnology for the treatment of human disease.BioDrugs publishes high quality, peer-reviewed research and up- to-date, critical reviews on the clinical development and therapeutic application of biotechnology-based pharmaceuticals, diagnostic products, and innovative technologies. The journal is an essential resource for R & D professionals in the biomedical science industries and academia, and clinicians with an interest in the leading edge technology in this exciting area.
常用鏈接
期刊論壇
|
中國SCI論文
|
期刊介紹
|
投稿信息
|
雜志官網(wǎng)
|
投稿鏈接
|
作者需知
|
PMC鏈接
|
Pubmed全文檢索
